InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,398.00
(
1.20%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.88
(
2.14%
)
Bitcoin
66,640.33
(
0.00%
)
Post# of 252229
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 833
Posts 119859
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ciotera post# 168898

Tuesday, 10/29/2013 4:39:37 PM

Tuesday, October 29, 2013 4:39:37 PM

Post# of 252229
GILD—In US market, Stribild is #1 HIV regimen and Complera is #2 regimen in all treatment settings. I.e. Atripla and PI-based regimens are all but obsolete. (Source: today’s CC.)

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up